Resolution criteria on PolyGram: As of market creation, ICU Medical is estimated to release earnings on May 7, 2026. The Street consensus estimate for ICU Medical’s non-GAAP EPS for the relevant quarter is $1.75 as of market creation. This market will resolve to "Yes" if ICU Medical reports non-GAAP EPS greater than $1.75 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If ICU Medical releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha.
PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.
Market outcomes
| Will ICU Medical (ICUI) beat quarterly earnings? | 100% YES | 0% NO |
ICU Medical will release its quarterly earnings on 7 May 2026, with the Street consensus non-GAAP EPS estimate set at $1.75. The market resolves "Yes" if the company reports earnings exceeding this threshold, "No" otherwise. On Polymarket's order book, the current implied probability stands at 100% YES, reflecting either extreme confidence in a beat or minimal liquidity at current pricing.
A 100% implied probability on an earnings beat is historically uncommon and typically signals either exceptionally strong forward guidance, recent analyst upgrades, or thin order-book depth. ICU Medical has historically demonstrated consistent execution in its infusion systems and critical care segments, though earnings surprises—both positive and negative—do occur across the medical device sector. Comparable companies in the space have seen implied probabilities of 70–85% on earnings beats, suggesting the current pricing may reflect either specific bullish catalysts or limited market participation at these levels.
Traders should monitor ICU Medical's pre-earnings guidance updates, any management commentary on supply chain or demand conditions, and broader sector trends affecting hospital capital expenditure. The company's recent quarterly performance, particularly trends in its core infusion and oncology product lines, will shape expectations heading into the release. Any material announcements regarding product launches, regulatory approvals, or acquisition activity in the weeks before 7 May could shift the order book materially from current levels.
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom
The Indiana University School of Medicine (IUSM) is a major, multi-campus medical school located throughout the U.S. state of Indiana and is both the undergraduate and graduate medical school of Indiana University. There are nine campuses throughout the state; the principal research, educational, and medical center is located on the campus of Indiana Univers
The Extended Duration Orbiter (EDO) program was a project by NASA to prepare for long-term (months) microgravity research aboard Space Station Freedom, which later evolved into the International Space Station. Scientists and NASA needed practical experience in managing progressively longer times for their experiments. The original Space Shuttle configuration
The Israeli Medical Corps is a corps responsible for providing healthcare services and medical treatment and instruction to all levels of the IDF.
This market settles from the official outcome published at https://seekingalpha.com/. A proposer submits the final result to the UMA optimistic oracle on Polygon; the two-hour dispute window closes and payouts clear in USDC.
The mechanics for trading "Will ICU Medical (ICUI) beat quarterly earnings?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.
$616 in lifetime turnover and $0 of resting liquidity puts this market in the below the median by volume for finance contracts on PolyGram. Order-book depth is thin — large orders may need to be split across the book or executed as limit orders.
The market has been open for under a month — fresh enough that information asymmetry remains a real factor.
Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.
As of today, traders on Polymarket price this outcome at 100%. The number updates continuously as the order book clears. PolyGram mirrors the same live odds with locale-aware formatting and USDC settlement.
Resolution is sourced from https://seekingalpha.com/. Settlement is executed by the UMA optimistic oracle on Polygon, with a 2-hour dispute window before payouts clear.
This prediction market is scheduled to close on 7 May 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.
To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.
When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.
Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.
Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.
Explore more prediction market odds and trading opportunities on PolyGram: